- UPSpace Home
- →
- Health Sciences
- →
- Physiology
- →
- Browsing Physiology by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Physiology by Author "Van den Bout, Jan Iman"
Now showing items 1-8 of 8
-
Visagie, M.H. (Michelle Helen); Van den Bout, Jan Iman; Joubert, Annie M. (Public Library of Science, 2017-04-14)Clinical trials have revealed that the potential anticancer agent, 2-methoxyestradiol (2ME2) has limitations due to its low bioavailability. Subsequently, 2ME2 derivatives including (8R, 13S,14S,17S)-2-ethyl-13-methyl- ...
-
Ncube, Keith Ntokozo; Jurgens, Tamarin; Steenkamp, Vanessa; Cromarty, Allan Duncan; Van den Bout, Jan Iman (MDPI, 2023-05-19)Three-dimensional cell culture models are increasingly adopted as preferred pre-clinical drug testing platforms, as they circumvent limitations associated with traditional monolayer cell cultures. However, many of these ...
-
Visuttijai, Kittichate; Pettersson, Jennifer; Azar, Yashar Mehrbani; Van den Bout, Jan Iman; Orndal, Charlotte; Marcickiewicz, Janusz; Nilsson, Staffan; Hornquist, Michael; Olsson, Bjorn; Ejeskar, Katarina; Behboudi, Afrouz (Public Library of Science, 2016-10-07)Myosin-1C (MYO1C) is a tumor suppressor candidate located in a region of recurrent losses distal to TP53. Myo1c can tightly and specifically bind to PIP2, the substrate of Phosphoinositide 3-kinase (PI3K), and to Rictor, ...
-
Nkandeu, D.S. (Danielle Sandra); Van den Bout, Jan Iman; Cronjé, Marianne J.; Van Papendorp, D.H. (Dirk Hermanus), 1949-; Joubert, Anna Margaretha (Karger Publishers, 2018)BACKGROUND : 2-Methoxyestradiol (2ME2) is an endogenous metabolite of 17-β-estradiol with anti-proliferative and anti-angiogenic properties. Due to 2ME2’s rapid metabolism and low oral bioavailability in in vivo settings, ...
-
Theron, Anne Elisabeth; Prudent, Renaud; Nolte, Elsie M.; Van den Bout, Jan Iman; Punchoo, Rivak; Marais, Sumari; Du Toit, Peet J.; Hlophe, Yvette Nkondo; Van Papendorp, D.H. (Dirk Hermanus), 1949-; Lafanechere, Laurence; Joubert, Annie M. (Springer, 2015-02)PURPOSE : 2-Methoxyestradiol (2ME) is a promising anticancer agent that disrupts the integrity and dynamics of the spindle network. In order to overcome the pharmacokinetic constraints of this compound, a panel of ...
-
Botes, Mandie; Jurgens, Tamarin; Riahi, Zohreh; Visagie, M.H. (Michelle Helen); Janse van Vuuren, Rustelle; Joubert, Annie M.; Van den Bout, Jan Iman (BioMed Central, 2018-11-19)BACKGROUND : 2-Methoxyestradiol (2ME2) is an estradiol metabolite with well documented antiproliferative properties in many cancer cell lines. However, it is rapidly metabolised in vivo which limits its clinical application. ...
-
Janse van Vuuren, Rustelle; Botes, Mandie; Jurgens, Tamarin; Joubert, Annie M.; Van den Bout, Jan Iman (BioMed Central, 2019-01-03)BACKGROUND : The estrogen metabolite 2-methoxyestradiol (2ME2) and a number of synthesised derivatives have been shown to bind to microtubules thereby arresting cancer cells in mitosis which leads to apoptosis. In ...
-
Van der Bijl, Ivo; Nawaz, Kalim; Kazlauskaite, Ugne; Van Stalborch, Anne-Marieke; Tol, Simon; Jimenez Orgaz, Ana; Van den Bout, Jan Iman; Reinhard, Nathalie R.; Sonnenberg, Arnoud; Margadant, Coert (Elsevier, 2020-11)Collective cell behaviour during embryogenesis and tissue repair requires the coordination of intercellular junctions, cytoskeleton-dependent shape changes controlled by Rho GTPases, and integrin-dependent cell-matrix ...
Now showing items 1-8 of 8